The same study found that the peripheral oedema index, enhancement percentage, and the maximum diameter of the tumour were significantly higher in the high-grade than the low-grade tumors; therefore, VEGF could be used as a biomarker for glioma invasion [32]. This evidence concerns the gene VEGFA and glioma.